Giuseppe Limongelli
Seconda Università degli Studi di Napoli
404 Papers
1.1K Citations
Giuseppe Limongelli is an academic researcher from Seconda Università degli Studi di Napoli. The author has contributed to research in topics: Medicine & Heart failure. The author has an hindex of 49, co-authored 315 publications. Previous affiliations of Giuseppe Limongelli include University College London & St Bartholomew's Hospital.
Chat about Author
Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Perry M. Elliott,Aris Anastasakis,Michael A. Borger,Martin Borggrefe,Franco Cecchi,Philippe Charron,Albert Hagège,Antoine Lafont,Giuseppe Limongelli,Heiko Mahrholdt,William J. McKenna,Jens Mogensen,Petros Nihoyannopoulos,Stefano Nistri,Petronella G. Pieper,Burkert Pieske,Claudio Rapezzi,Frans H. Rutten,Christoph Tillmanns,Hugh Watkins +19 more
TL;DR: The objective of this study was to establish a baseline level of confidence that the once-in-a-lifetime implantation trial—Reduce Inappropriate Therapy protocol can be trusted to provide safe and effective treatment for cardiac arrhythmia and stroke-like episodes.
3.9K
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
Constantinos O'Mahony,Fatima Jichi,Menelaos Pavlou,Lorenzo Monserrat,Aristides Anastasakis,Claudio Rapezzi,Elena Biagini,Juan R. Gimeno,Giuseppe Limongelli,William J. McKenna,Rumana Z Omar,Perry M. Elliott +11 more
TL;DR: This is the first validated SCD risk prediction model for patients with HCM and provides accurate individualized estimates for the probability of SCD using readily collected clinical parameters.
1K
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice : a position statement of the ESC working group on myocardial and pericardial diseases
Yigal M. Pinto,Perry M. Elliott,Eloisa Arbustini,Yehuda Adler,Aristides Anastasakis,Michael Böhm,Denis Duboc,Juan R. Gimeno,Pascal de Groote,Pascal de Groote,Massimo Imazio,Stephane Heymans,Karin Klingel,Michel Komajda,Giuseppe Limongelli,Aleš Linhart,Jens Mogensen,James C. Moon,Petronella G. Pieper,Petar M. Seferovic,Stephan Schueler,José Luis Zamorano,Alida L.P. Caforio,P. Charron +23 more
TL;DR: A revised definition of dilated cardiomyopathy (DCM) is proposed in an attempt to bridge the gap between recent understanding of the disease spectrum and its clinical presentation in relatives, which is key for early diagnosis and the institution of potential preventative measures.
1K
Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target
Enrica Golia,Giuseppe Limongelli,Francesco Natale,Fabio Fimiani,Valeria Maddaloni,Ivana Pariggiano,Renatomaria Bianchi,Mario Crisci,Ludovica D’Acierno,Roberto Giordano,Gaetano Di Palma,Marianna Conte,Paolo Golino,Maria Giovanna Russo,Raffaele Calabrò,Paolo Calabrò +15 more
TL;DR: The epidemiological observation that biomarkers of inflammation are associated with clinical cardiovascular risk supports the theory that targeted anti-inflammatory treatment appears to be a promising strategy in reducing residual cardiovascular risk on the background of traditional medical therapy.
500
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Perry M. Elliott,Aris Anastasakis,Michael A. Borger,Martin Borggrefe,Franco Cecchi,P. Charron,Albert Hagège,Antoine Lafont,Giuseppe Limongelli,Heiko Mahrholdt,Wiliam J. McKenna,Jens Mogensen,Petros Nihoyannopoulos,Stefano Nistri,Petronella G. Pieper,Burkert Pieske,Claudio Rapezzi,Frans H. Rutten,Christoph Tillmanns,Hugh Watkins +19 more
TL;DR: Authors/Task Force Members: Perry M. Elliott* (Chairperson), Aris Anastasakis (Greece), Michael A. Nihoyannopoulos (UK), Stefano Nistri (Italy), Petronella G. Pieper (Netherlands), Burkert Pieske (Austria), Claudio Rapezzi (Italy) and Christoph Tillmanns (Germany).